Circumventing paclitaxel resistance in breast cancer cells using a nanoemulsion system and determining its efficacy via an impedance biosensor. Issue 10 (8th April 2021)

• Record Type: Journal Article
• Authors: Attari, Farnoosh; Hazim, Habibullah; Zandi, Ashkan; Mazarei, Zeinab; Rafati, Hasan
• Is Part Of: Analyst. Volume 146:Issue 10(2021)
• Page Start: 3225
• Page End: 3233
• Publication Date: 2021-04-08
• Subjects: Chemistry, Analytic -- Periodicals; 543
• DOI: 10.1039/d0an02013c
• Languages: English
• ISSNs: 0003-2654

Abstract

Abstract : Nanocarriers as one of the best strategies to circumvent drug resistance. Abstract : One of the best strategies to circumvent drug resistance is the employment of nanocarriers. For the current study, we have employed a nanoemulsion formulation of paclitaxel (PTX) to bypass drug resistance in the MDA-MB-231 cell line and impedance sensing biosensors to determine the exact time that PTX-NE induced apoptosis. Our MTT results demonstrated that PTX treatment could not reduce MDA-MB-231 cell viability to IC50 even after three days. However, the employment of the reagent TPGS (inhibitor of drug resistance) combined with paclitaxel could partially obviate PTX resistance. Next, the nanoemulsion form of PTX (PTX-NE) was fabricated employing the essential oil of the Satureja khuzestanica plant and was characterized using DLS and TEM methods. Our data showed that after 72 hours, PTX-NE at 250 nM concentration could induce a 50% reduction in cell viability. Moreover, annexin/PI and cell cycle analysis confirmed the apoptotic effect of PTX-NE on cancer cells. Lastly, we measured the impedance of MDA-MB-231 cells treated with the free and nanoemulsion forms of PTX. A significant decrease in the mean impedance of PTX-NE treated cells could be observed after 40 hours. To conclude, we have demonstrated here that PTX-NE could circumvent resistance and induce apoptosis in PTX-resistant breast cancer cells, which could be inferred from their impedance measurement.